Amir Hafeez currently serves as the Senior Global Lead Physician for ADC and Solid Tumors at Genmab since January 2025, while also holding the position of Founder and Chief Medical Officer at BestCure Biopharma, which focuses on biopharma clinical development consulting from January 2024. Prior roles include Head of Clinical Development at BioXcel Therapeutics, Inc. from January 2022 to January 2024, and Senior Vice President as Head of Clinical Research & Development at NextCure, Inc. during 2022. Additionally, Amir served as Executive Medical Director at Gilead Sciences/Immunomedics from January 2019 to January 2022, where contributions were made to ADC-Trodelvy. Currently pursuing an Executive MBA at Cornell University, Amir has been enrolled since January 2023 and is expected to graduate in May 2027.
This person is not in the org chart
This person is not in any teams
This person is not in any offices